Urgent.News

One page, thousands of outlets. See who else covered it.

Editions

More in Business

Stockholm’s Pixelgen Technologies secures €13.26 million to advance spatial mapping of cell-surface proteins

Pixelgen Technologies, a Stockholm-based life sciences company that claims to have developed the first high-throughput platform for mapping molecular cell architecture, has closed an oversubscribed…

  • Stockholm-based life sciences firm Pixelgen Technologies secures €13.26 million in Series B funding.
  • New investors Flat Capital and existing investors Industrifonden and Navigare Ventures participate.
  • Funding will support global expansion and accelerate commercialisation of Proxiome Kit technology.

More from Thursday 20 August →